A PARADIGM SHIFT IN THE TREATMENT OF PATIENTS WITH RESECTABLE PANCREATIC CANCER-Reference-Cited by-同舟云学术

A PARADIGM SHIFT IN THE TREATMENT OF PATIENTS WITH RESECTABLE PANCREATIC CANCER

Published:2020-07-06 Issue:3 Volume:19 Page:156-163
ISSN:2312-3168
Container-title:Siberian journal of oncology
language:
Short-container-title:Sib. onkol. ž.

Author:

Antonova E. Yu.¹,Bazin I. S.²,Garin A. M.¹,Pokataev I. A.¹^ORCID,Sagaidak I. B.¹,Polyakov A. N.¹^ORCID,Chihareva Y. E.¹,Volkov A. Yu.¹,Bazina I. V.³

Affiliation:

1. N.N. Blokhin National Medical Research Center of Oncology

2. N.N. Blokhin National Medical Research Center of Oncology; Tver State Medical University

3. Pirogov Russian National Research Medical University

Abstract

Purpose of the study was to provide medical oncologists and surgeons specializing in the treatment of pancreatic cancer patients with the most recent information on the importance and role of chemotherapy in the treatment of patients with resectable and borderline resectable pancreatic cancer.Material and Methods. Pubmed and COSMIC databases were used for literature search. Reports of the executive authorities in the field of Health Care of the Russian Federation, as well as worldwide data regarding morbidity and mortality of patients with pancreatic cancer were analyzed. The data of retrospective and prospective clinical trials were studied.Results. Based on the analysis of the most recent publications, the authors provided data on modern approaches to the treatment of operable pancreatic cancer.Conclusion. The data presented in the article summarize results of recent clinical trials. This will allow oncologists to choose the most correct and personalized tactics for the management of patients with resectable and borderline resectable pancreatic cancer.

Publisher

Tomsk Cancer Research Institute

Subject

Cancer Research,Oncology

Reference38 articles.

1. Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6): 394–424. doi:10.3322/caac.21492.

2. McGuigan A., Kelly P., Turkington R.C., Jones C., Coleman H.G., McCain R.S. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol. 2018; 24(43): 4846–4861. doi: 10.3748/wjg.v24.i43.4846.

3. Ferlay J., Ervik M., Lam F., Colombet M., Mery L., Piñeros M., Bray F. Global cancer observatory: cancer today. Lyon, France: International Agency for Research on Cancer [Internet]. URL: http://gco.iarc.fr/tomorrow/graphic-isotype?type=1&population=900&mode=population&sex=0&cancer=39&age_group=value&apc_male=0&apc_female=0 (cited 23.06.2019).

4. Kaprin A.D., Starinsky V.V., Petrova G.V. The status of cancer care for the population of Russia in 2017. Moscow, 2018. P. 86–89 (in Russian).

5. Russian Oncology Association. Pancreas cancer. Clinical recommendations. 2017. 35 p. (in Russian).